Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:ATCCode |
none
|
| gptkbp:CASNumber |
none
|
| gptkbp:clinicalTrialPhase |
Phase 3
|
| gptkbp:developedBy |
gptkb:Portola_Pharmaceuticals
|
| gptkbp:hasTherapeuticUse |
gptkb:pemphigus_vulgaris
autoimmune diseases |
| gptkbp:legalStatus |
investigational
|
| gptkbp:mechanismOfAction |
Bruton's tyrosine kinase inhibitor
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:bfsParent |
gptkb:Principia_Biopharma
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
PRN1008
|